Found 0 matching trials
Bispecific Antibody-Based Salvage Therapy Followed by CAR-T ± ASCT in R/R Aggressive B-Cell Lymphoma PHASE2 This study consists of two sequential treatment phases. In the first phase,...
Show More Location
Institute of Hematology & Blood Diseases Hospital
Learn More & Join Trial
NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS PHASE1 This is a single-arm, open-label, multi-center, Phase 1 study to determine ...
Show More Status
Active Not Recruiting
Location
Colorado Blood Cancer Institute
Learn More & Join Trial
TAA6 Cell Injection In The Treatment of Patients With Relapsed / Refractory Acute Myeloid Leukemia NA This is a clinical study of TAA6 cell injection in the treatment of patient...
Show More Location
Anhui Provincial Hospital
Learn More & Join Trial
Study of αPD1-MSLN-CAR T Cells to Evaluate the Safety, Tolerability, and Effectiveness for Patients With MSLN-positive Advanced Solid Tumors PHASE1 This is a single arm, open-label, dose escalation clinical study to evaluat...
Show More Location
National Cancer Center Cancer Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
CRISPR Delivered Anti-BCMA Car-T Therapy for Relapsed or Refractory Multiple Myeloma PHASE1 This phase Ib trial tests the safety, side effects and best dose of cluster...
Show More Location
University of California, San Francisco
Learn More & Join Trial
HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma PHASE1 The purpose of this study is to learn whether it is safe to give HER2-CAR T...
Show More Location
Texas Children's Hospital
Learn More & Join Trial
Safety and Effectiveness of Immunotherapy With Autologous HIV-Specific CD8 Cells in HIV Infected Adults PHASE1 Effective, suppressive treatment for HIV infected patients can be a major c...
Show More Location
Fred Hutchinson Cancer Research Center
Learn More & Join Trial
Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Stage IV Melanoma PHASE1 RATIONALE: Biological therapies, such as therapeutic autologous lymphocytes...
Show More Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Learn More & Join Trial
A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1) PHASE1 This is a Phase 1/2, open-label, multi-center, multi-cohort, non-randomized...
Show More Location
Nkarta Investigational Site
Learn More & Join Trial
Safely Delivered Targeted High-dose Irradiation Followed by Adoptive Immunotherapy with Regulatory and Conventional T Cells to Increase Potency of Hematopoietic Stem Cell Transplantation in High-risk Acute Leukemia NA The study is a monocentric, interventional study that evaluates the efficac...
Show More Location
Università degli Studi di Perugia
Learn More & Join Trial